Amicus Therapeutics
Lynn D. Bleil is the current Director at Amicus Therapeutics. Lynn has also held positions at Navigen, Inc., Halo Neuroscience, Sonova Group, Stericycle, and the Sorenson Global Impact Investing Center. Lynn has been a Board Member for Utah Youth Orchestras & Ensembles and a Board Trustee for the U.S. Ski Team Foundation. Lynn is also the Governing Board Chair for Intermountain Wasatch Back Hospitals Board.
Lynn D. Bleil has a Master of Business Administration (M.B.A.) from Stanford University Graduate School of Business in the field of health policy. Lynn also has a BSE from Princeton University in chemical engineering with a minor in East Asian studies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Amicus Therapeutics
4 followers
Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.